| PNGAX | VIHAX | PNGAX / VIHAX | |
| Total Expense Ratio | 1.07 | 0.17 | 629% |
| Annual Report Gross Expense Ratio | 1.27 | 0.17 | 747% |
| Fund Existence | 29 years | 10 years | - |
| Gain YTD | 30.379 | 30.161 | 101% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.03B | 13.8B | 7% |
| Annual Yield % from dividends | 2.02 | 3.92 | 51% |
| Returns for 1 year | 27.04 | 27.67 | 98% |
| Returns for 3 years | 69.24 | 54.08 | 128% |
| Returns for 5 years | 78.05 | 63.09 | 124% |
| Returns for 10 years | 93.13 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUXX | 20.30 | 0.01 | +0.02% |
| Strive Enhanced Income Short MaturityETF | |||
| JHAC | 15.24 | N/A | N/A |
| JHancock Fundamental All Cap Core ETF | |||
| BIB | 74.47 | -1.60 | -2.10% |
| ProShares Ultra Nasdaq Biotechnology | |||
| MVLL | 24.32 | -1.05 | -4.14% |
| GraniteShares 2x Long MRVL Daily ETF | |||
| USD | 104.21 | -8.17 | -7.27% |
| ProShares Ultra Semiconductors | |||